Growth Metrics

Palvella Therapeutics (PVLA) Shares Issued (2016 - 2026)

Palvella Therapeutics has reported Shares Issued over the past 10 years, most recently at -$6.8 million for Q4 2022.

  • Quarterly Shares Issued changed N/A to -$6.8 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $95000.0 through Dec 2022, down 88.65% year-over-year, with the annual reading at $763000.0 for FY2025, N/A changed from the prior year.
  • Shares Issued was -$6.8 million for Q4 2022 at Palvella Therapeutics, down from $6.8 million in the prior quarter.
  • Over five years, Shares Issued peaked at $18.9 million in Q2 2021 and troughed at -$46.2 million in Q4 2018.
  • The 5-year median for Shares Issued is $182000.0 (2018), against an average of -$2.4 million.
  • Year-over-year, Shares Issued tumbled 25488.46% in 2018 and then surged 6878.97% in 2021.
  • A 5-year view of Shares Issued shows it stood at -$46.2 million in 2018, then surged by 100.57% to $264000.0 in 2019, then grew by 10.23% to $291000.0 in 2020, then plummeted by 6311.68% to -$18.1 million in 2021, then surged by 62.23% to -$6.8 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Shares Issued are -$6.8 million (Q4 2022), $6.8 million (Q3 2022), and $10000.0 (Q2 2022).